Cargando…
Heterozygous and Homozygous JAK2(V617F) States Modeled by Induced Pluripotent Stem Cells from Myeloproliferative Neoplasm Patients
JAK2(V617F) is the predominant mutation in myeloproliferative neoplasms (MPN). Modeling MPN in a human context might be helpful for the screening of molecules targeting JAK2 and its intracellular signaling. We describe here the derivation of induced pluripotent stem (iPS) cell lines from 2 polycythe...
Autores principales: | Saliba, Joseph, Hamidi, Sofiane, Lenglet, Gaëlle, Langlois, Thierry, Yin, Jingkui, Cabagnols, Xénia, Secardin, Lise, Legrand, Céline, Galy, Anne, Opolon, Paule, Benyahia, Baya, Solary, Eric, Bernard, Olivier A., Chen, Longyun, Debili, Najet, Raslova, Hana, Norol, Françoise, Vainchenker, William, Plo, Isabelle, Di Stefano, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774801/ https://www.ncbi.nlm.nih.gov/pubmed/24066127 http://dx.doi.org/10.1371/journal.pone.0074257 |
Ejemplares similares
-
Role of Rho-GTPases in megakaryopoiesis
por: Vainchenker, William, et al.
Publicado: (2021) -
Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms
por: Secardin, Lise, et al.
Publicado: (2021) -
P53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesis
por: Mahfoudhi, Emna, et al.
Publicado: (2016) -
p19(INK4d) Controls Hematopoietic Stem Cells in a Cell-Autonomous Manner during Genotoxic Stress and through the Microenvironment during Aging
por: Hilpert, Morgane, et al.
Publicado: (2014) -
JAK2(V617F) myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML
por: Dagher, Tracy, et al.
Publicado: (2020)